These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36119543)

  • 21. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kitabatake S; Kuzuya T; Nonogaki K; Shimizu J; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J; Satomura S
    Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case report: 8 years after liver transplantation: de novo hepatocellular carcinoma 8 months after HCV clearance through IFN-free antiviral therapy.
    Ramadori G; Bosio P; Moriconi F; Malik IA
    BMC Cancer; 2018 Mar; 18(1):257. PubMed ID: 29510685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma.
    Yamashiki N; Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Inoue K; Okamura A; Arita S; Harada K
    Oncol Rep; 1999; 6(6):1229-32. PubMed ID: 10523686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models.
    Wongjarupong N; Negron-Ocasio GM; Chaiteerakij R; Addissie BD; Mohamed EA; Mara KC; Harmsen WS; Theobald JP; Peters BE; Balsanek JG; Ward MM; Giama NH; Venkatesh SK; Harnois DM; Charlton MR; Yamada H; Algeciras-Schimnich A; Snyder MR; Therneau TM; Roberts LR
    World J Gastroenterol; 2018 Mar; 24(12):1321-1331. PubMed ID: 29599607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L; Fehérvári I; Görög D; Nemes B; Szabó J; Gerlei Z; Végső G; Kóbori L; Máthé Z
    Transplant Proc; 2015 Sep; 47(7):2201-6. PubMed ID: 26361680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The studies on early warning of Lens culinaris-reactive alpha-Fetoprotein (AFP-L3) detecting in primary hepatocellular carcinoma].
    Li YL; Ma HB; Guo JX; Shi JB; Xu J; Liu AX; Yang LH; Li BA; Mao YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):336-8. PubMed ID: 19469167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma.
    Miyaaki H; Nakashima O; Kurogi M; Eguchi K; Kojiro M
    J Gastroenterol; 2007 Dec; 42(12):962-8. PubMed ID: 18085353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver Allograft Failure After Nivolumab Treatment-A Case Report With Systematic Literature Research.
    Gassmann D; Weiler S; Mertens JC; Reiner CS; Vrugt B; Nägeli M; Mangana J; Müllhaupt B; Jenni F; Misselwitz B
    Transplant Direct; 2018 Aug; 4(8):e376. PubMed ID: 30255136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of curability and prediction of prognosis after surgical treatment for hepatocellular carcinoma by lens culinaris agglutinin-reactive alpha-fetoprotein.
    Okuda K; Tanaka M; Kanazawa N; Nagashima J; Satomura S; Kinoshita H; Eriguchi N; Aoyagi S; Kojiro M
    Int J Oncol; 1999 Feb; 14(2):265-71. PubMed ID: 9917501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of serum AFP, AFP-L3, and GP73 in monitoring short-term treatment response and recurrence of hepatocellular carcinoma after radiofrequency ablation.
    Wang NY; Wang C; Li W; Wang GJ; Cui GZ; He H; Zhao HJ
    Asian Pac J Cancer Prev; 2014; 15(4):1539-44. PubMed ID: 24641364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent topics on α-fetoprotein.
    Nakao K; Ichikawa T
    Hepatol Res; 2013 Aug; 43(8):820-5. PubMed ID: 23347387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in highly sensitive alpha-fetoprotein for the prediction of the outcome in patients with hepatocellular carcinoma after hepatectomy.
    Toyoda H; Kumada T; Tada T; Ito T; Maeda A; Kaneoka Y; Kagebayashi C; Satomura S
    Cancer Med; 2014 Jun; 3(3):643-51. PubMed ID: 24591342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lenvatinib combined nivolumab injection followed by extended right hepatectomy is a feasible treatment for patients with massive hepatocellular carcinoma: a case report.
    Chen X; Zhang Y; Zhang N; Ge Y; Jia W
    Onco Targets Ther; 2019; 12():7355-7359. PubMed ID: 31686845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lens culinaris agglutinin-reactive α-fetoprotein decline after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma predicts survival.
    Huang C; Sheng S; Sun X; Liu J; Huang G
    Clin Chim Acta; 2014 Apr; 431():232-8. PubMed ID: 24565960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical role of combining alpha-fetoprotein and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein for hepatocellular carcinoma: Evidence from literature and an original study.
    Chen S; Li J; Tan X; Xu Q; Mo Y; Qin H; Zhou L; Ma L; Wei Z
    J Clin Lab Anal; 2020 Jul; 34(7):e23262. PubMed ID: 32167614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma.
    Núñez KG; Sandow T; Fort D; Patel J; Hibino M; Carmody I; Cohen AJ; Thevenot P
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma.
    Yoshida S; Kurokohchi K; Arima K; Masaki T; Hosomi N; Funaki T; Murota M; Kita Y; Watanabe S; Kuriyama S
    Int J Oncol; 2002 Feb; 20(2):305-9. PubMed ID: 11788893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC.
    Wang Y; Shen Z; Zhu Z; Han R; Huai M
    Hepat Mon; 2011 Mar; 11(3):195-9. PubMed ID: 22087143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas.
    Yamashita F; Tanaka M; Satomura S; Tanikawa K
    Gastroenterology; 1996 Oct; 111(4):996-1001. PubMed ID: 8831594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC.
    Yamamoto K; Imamura H; Matsuyama Y; Kume Y; Ikeda H; Norman GL; Shums Z; Aoki T; Hasegawa K; Beck Y; Sugawara Y; Kokudo N
    J Gastroenterol; 2010 Dec; 45(12):1272-82. PubMed ID: 20625772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.